MET and gastric cancer: In a patient-derived MET proto-oncogene, receptor tyrosine kinase (MET)-amplified GC model, exosomal MET depletion significantly decreased invasiveness; when paired with MET and/or vascular endothelial growth factor (VEGF)-R2 inhibition, an additive therapeutic effect was induced.